ARYL AND HETEROARYL FUSED LACTAMS
This invention relates to compounds of general formula (I) in which R1, R2, U, V, L, M, R5, m, X, Y and Z are as defined herein, and the pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and co...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ZEHNDER LUKE RAYMOND WYTHES MARTIN JAMES EDWARDS MARTIN PAUL TATLOCK JOHN HOWARD KUMPF ROBERT ARNOLD KUNG PEI-PEI SUTTON SCOTT CHANNING MCAPLINE INDRAWAN JAMES RUI EUGENE YUANJIN NINKOVIC SACHA |
| description | This invention relates to compounds of general formula (I) in which R1, R2, U, V, L, M, R5, m, X, Y and Z are as defined herein, and the pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2014179667A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2014179667A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2014179667A13</originalsourceid><addsrcrecordid>eNrjZFB0DIr0UXD0c1HwcA1xDfIHc91Cg11dFHwcnUMcfYN5GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakl8aLCRgaGJobmlmZm5o6ExcaoAle8jGA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ARYL AND HETEROARYL FUSED LACTAMS</title><source>esp@cenet</source><creator>ZEHNDER LUKE RAYMOND ; WYTHES MARTIN JAMES ; EDWARDS MARTIN PAUL ; TATLOCK JOHN HOWARD ; KUMPF ROBERT ARNOLD ; KUNG PEI-PEI ; SUTTON SCOTT CHANNING ; MCAPLINE INDRAWAN JAMES ; RUI EUGENE YUANJIN ; NINKOVIC SACHA</creator><creatorcontrib>ZEHNDER LUKE RAYMOND ; WYTHES MARTIN JAMES ; EDWARDS MARTIN PAUL ; TATLOCK JOHN HOWARD ; KUMPF ROBERT ARNOLD ; KUNG PEI-PEI ; SUTTON SCOTT CHANNING ; MCAPLINE INDRAWAN JAMES ; RUI EUGENE YUANJIN ; NINKOVIC SACHA</creatorcontrib><description>This invention relates to compounds of general formula (I) in which R1, R2, U, V, L, M, R5, m, X, Y and Z are as defined herein, and the pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140626&DB=EPODOC&CC=US&NR=2014179667A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140626&DB=EPODOC&CC=US&NR=2014179667A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZEHNDER LUKE RAYMOND</creatorcontrib><creatorcontrib>WYTHES MARTIN JAMES</creatorcontrib><creatorcontrib>EDWARDS MARTIN PAUL</creatorcontrib><creatorcontrib>TATLOCK JOHN HOWARD</creatorcontrib><creatorcontrib>KUMPF ROBERT ARNOLD</creatorcontrib><creatorcontrib>KUNG PEI-PEI</creatorcontrib><creatorcontrib>SUTTON SCOTT CHANNING</creatorcontrib><creatorcontrib>MCAPLINE INDRAWAN JAMES</creatorcontrib><creatorcontrib>RUI EUGENE YUANJIN</creatorcontrib><creatorcontrib>NINKOVIC SACHA</creatorcontrib><title>ARYL AND HETEROARYL FUSED LACTAMS</title><description>This invention relates to compounds of general formula (I) in which R1, R2, U, V, L, M, R5, m, X, Y and Z are as defined herein, and the pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFB0DIr0UXD0c1HwcA1xDfIHc91Cg11dFHwcnUMcfYN5GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakl8aLCRgaGJobmlmZm5o6ExcaoAle8jGA</recordid><startdate>20140626</startdate><enddate>20140626</enddate><creator>ZEHNDER LUKE RAYMOND</creator><creator>WYTHES MARTIN JAMES</creator><creator>EDWARDS MARTIN PAUL</creator><creator>TATLOCK JOHN HOWARD</creator><creator>KUMPF ROBERT ARNOLD</creator><creator>KUNG PEI-PEI</creator><creator>SUTTON SCOTT CHANNING</creator><creator>MCAPLINE INDRAWAN JAMES</creator><creator>RUI EUGENE YUANJIN</creator><creator>NINKOVIC SACHA</creator><scope>EVB</scope></search><sort><creationdate>20140626</creationdate><title>ARYL AND HETEROARYL FUSED LACTAMS</title><author>ZEHNDER LUKE RAYMOND ; WYTHES MARTIN JAMES ; EDWARDS MARTIN PAUL ; TATLOCK JOHN HOWARD ; KUMPF ROBERT ARNOLD ; KUNG PEI-PEI ; SUTTON SCOTT CHANNING ; MCAPLINE INDRAWAN JAMES ; RUI EUGENE YUANJIN ; NINKOVIC SACHA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2014179667A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2014</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>ZEHNDER LUKE RAYMOND</creatorcontrib><creatorcontrib>WYTHES MARTIN JAMES</creatorcontrib><creatorcontrib>EDWARDS MARTIN PAUL</creatorcontrib><creatorcontrib>TATLOCK JOHN HOWARD</creatorcontrib><creatorcontrib>KUMPF ROBERT ARNOLD</creatorcontrib><creatorcontrib>KUNG PEI-PEI</creatorcontrib><creatorcontrib>SUTTON SCOTT CHANNING</creatorcontrib><creatorcontrib>MCAPLINE INDRAWAN JAMES</creatorcontrib><creatorcontrib>RUI EUGENE YUANJIN</creatorcontrib><creatorcontrib>NINKOVIC SACHA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZEHNDER LUKE RAYMOND</au><au>WYTHES MARTIN JAMES</au><au>EDWARDS MARTIN PAUL</au><au>TATLOCK JOHN HOWARD</au><au>KUMPF ROBERT ARNOLD</au><au>KUNG PEI-PEI</au><au>SUTTON SCOTT CHANNING</au><au>MCAPLINE INDRAWAN JAMES</au><au>RUI EUGENE YUANJIN</au><au>NINKOVIC SACHA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ARYL AND HETEROARYL FUSED LACTAMS</title><date>2014-06-26</date><risdate>2014</risdate><abstract>This invention relates to compounds of general formula (I) in which R1, R2, U, V, L, M, R5, m, X, Y and Z are as defined herein, and the pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2014179667A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
| title | ARYL AND HETEROARYL FUSED LACTAMS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T02%3A35%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZEHNDER%20LUKE%20RAYMOND&rft.date=2014-06-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2014179667A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |